Aptus Capital Advisors’s MasTec MTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Buy
819
+3
+0.4% +$1.15K ﹤0.01% 900
2026
Q1
$263K Buy
+816
New +$221K ﹤0.01% 920
2025
Q3
Sell
-1,340
Closed -$228K 1638
2025
Q2
$228K Buy
+1,340
New +$193K ﹤0.01% 906
2024
Q3
Sell
-21,616
Closed -$2.31M 1264
2024
Q2
$2.31M Sell
21,616
-8,754
-29% -$884K 0.04% 275
2024
Q1
$2.83M Sell
30,370
-639
-2% -$48.6K 0.05% 256
2023
Q4
$2.35M Buy
+31,009
New +$1.94M 0.06% 209

Other funds holding MTZ

Aptus Capital Advisors's MTZ Position: Q2 2026 in Review

Aptus Capital Advisors increased its MasTec (MTZ) stake by 0.37% in Q2 2026, buying an estimated $1.15K and bringing the position to 819 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Aptus Capital Advisors first reported a position in MTZ in Q4 2023 and has held it in 6 quarters since. The position peaked at $2.83M in Q1 2024. 911 funds tracked by Wall St. Rank hold MTZ as of Q2 2026.

  • Aptus Capital Advisors held 819 shares of MasTec worth $341K as of Q2 2026.
  • Aptus Capital Advisors bought 3 MasTec shares in Q2 2026, an estimated $1.15K.
  • MasTec made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #900 holding.
  • Aptus Capital Advisors first reported a position in MasTec in Q4 2023 and has held it in 6 quarters since.
  • Aptus Capital Advisors's MasTec position peaked at $2.83M in Q1 2024.
  • 911 funds tracked by Wall St. Rank held MasTec as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.